Market Cap 6.91M
Revenue (ttm) 90,000.00
Net Income (ttm) -13.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15,511.11%
Debt to Equity Ratio 0.00
Volume 3,357,400
Avg Vol 5,501,942
Day's Range N/A - N/A
Shares Out 30.44M
Stochastic %K 12%
Beta 1.19
Analysts Sell
Price Target $4.25

Company Profile

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon produ...

Industry: Biotechnology
Sector: Healthcare
Phone: 352 448 7797
Fax: 352 480 4620
Address:
2117 SW Highway 484, Ocala, United States
IamJdubs
IamJdubs Sep. 11 at 1:01 PM
$AIM looking bleak here
0 · Reply
Mewz444
Mewz444 Sep. 11 at 1:00 PM
$AIM with the ebola outbreak seems to be 0 shares availability for shorting ~ 🍋💦 squeeze time ⏲️
0 · Reply
Chessdoc
Chessdoc Sep. 11 at 11:20 AM
$AIM https://abcnews.com/Health/wireStory/africas-top-health-body-warns-congos-ebola-outbreak-136345198
2 · Reply
Mewz444
Mewz444 Sep. 11 at 10:36 AM
$AIM 💲💲💲
0 · Reply
dmat12
dmat12 Sep. 10 at 8:20 PM
$AIM How can a stock have such high volume as AIM has had for the past few weeks and trade in such a narrow range? Pre market trading and after hours trading volume is high. And the stock price doesn't move more than a cent. Is it shorts covering their naked positions? Is our market maker involved? Somebody please explain.
2 · Reply
Packmentality
Packmentality Sep. 10 at 5:44 PM
$AIM Has to be one of the most mysterious shares ever. $2.5 million changed hands today for a share no one is interested in?….there has to be something to it’s never say die existence….
0 · Reply
Agp1
Agp1 Sep. 10 at 1:11 PM
$AIM why does Equels insist on representing the science himself. He has no more credibility in my book. I want to hear from the doctors and scientists. Not a lawyer that should have retired years ago. The pattern.. he speaks, stock tanks.
1 · Reply
Mewz444
Mewz444 Sep. 10 at 11:40 AM
$AIM wow
0 · Reply
setforyou
setforyou Sep. 10 at 10:18 AM
$AIM I asked Grok the hot penny stocks to buy and swing! $ELBM $WKSP $WKSP $DARE $LUCY
0 · Reply
runner01
runner01 Sep. 9 at 5:26 PM
$AIM The scam that keeps on scamming. What a fkn joke management should be on trial. Save yourselves.
1 · Reply
Latest News on AIM
AIM ImmunoTech granted patent for Ampligen

2026-08-31T13:00:13.000Z - 13 days ago

AIM ImmunoTech granted patent for Ampligen


AIM ImmunoTech Quarterly report: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 5 weeks ago

AIM ImmunoTech Quarterly report: Q2 2026


AIM ImmunoTech Earnings release: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 5 weeks ago

AIM ImmunoTech Earnings release: Q2 2026


AIM ImmunoTech Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 2 months ago

AIM ImmunoTech Proxy statement: Proxy filing


AIM ImmunoTech Registration statement: Registration filing

Jun 18, 2026, 8:00 AM EDT - 2 months ago

AIM ImmunoTech Registration statement: Registration filing


AIM ImmunoTech Proxy statement: Proxy filing

Jun 15, 2026, 8:00 AM EDT - 3 months ago

AIM ImmunoTech Proxy statement: Proxy filing


AIM ImmunoTech Inc trading resumes

2026-06-09T13:50:10.000Z - 3 months ago

AIM ImmunoTech Inc trading resumes


AIM ImmunoTech announces $2.65M registered direct offering

2026-06-09T13:41:34.000Z - 3 months ago

AIM ImmunoTech announces $2.65M registered direct offering


AIM ImmunoTech Inc trading halted, news pending

2026-06-09T13:29:35.000Z - 3 months ago

AIM ImmunoTech Inc trading halted, news pending


AIM ImmunoTech Registration statement: Registration filing

Jun 8, 2026, 8:00 AM EDT - 3 months ago

AIM ImmunoTech Registration statement: Registration filing


3 Penny Stocks Drawing Market Attention, 6/2/26

2026-06-02T17:36:51.000Z - 3 months ago

3 Penny Stocks Drawing Market Attention, 6/2/26

ANY HKIT


AIM ImmunoTech Inc trading resumes

2026-05-20T19:20:11.000Z - 3 months ago

AIM ImmunoTech Inc trading resumes


AIM ImmunoTech announces $2.4M registered direct offering

2026-05-20T19:10:27.000Z - 3 months ago

AIM ImmunoTech announces $2.4M registered direct offering


AIM ImmunoTech Inc trading halted, news pending

2026-05-20T19:00:12.000Z - 3 months ago

AIM ImmunoTech Inc trading halted, news pending


CMMI Institute Completes Pilot for New AI Maturity (AIM) Framework

May 19, 2026, 11:41 AM EDT - 3 months ago

CMMI Institute Completes Pilot for New AI Maturity (AIM) Framework


AIM ImmunoTech Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

AIM ImmunoTech Quarterly report: Q1 2026


AIM ImmunoTech Transcript: Virtual Investor Closing Bell

Apr 16, 2026, 4:00 PM EDT - 5 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell


AIM ImmunoTech Provides Routine Update on Annual Filings

Apr 13, 2026, 6:00 PM EDT - 5 months ago

AIM ImmunoTech Provides Routine Update on Annual Filings


AIM ImmunoTech Annual report: Q4 2025

Mar 27, 2026, 4:00 PM EDT - 5 months ago

AIM ImmunoTech Annual report: Q4 2025


Biotech Alert: Searches spiking for these stocks today

2026-03-20T14:55:28.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today


Why Is AIM ImmunoTech Stock (AIM) Up Today?

2026-03-18T13:47:09.000Z - 5 months ago

Why Is AIM ImmunoTech Stock (AIM) Up Today?


AIM announces approval of patent for Ampligen in Japan

2026-03-18T12:51:46.000Z - 5 months ago

AIM announces approval of patent for Ampligen in Japan


AIM ImmunoTech Announces Closing of its Rights Offering

Mar 6, 2026, 7:00 PM EST - 6 months ago

AIM ImmunoTech Announces Closing of its Rights Offering


Biotech Alert: Searches spiking for these stocks today

2026-03-04T15:25:35.000Z - 6 months ago

Biotech Alert: Searches spiking for these stocks today


AIM ImmunoTech announces preliminary results of rights offering

2026-03-04T14:05:33.000Z - 6 months ago

AIM ImmunoTech announces preliminary results of rights offering


AIM ImmunoTech Transcript: Virtual Investor Closing Bell

Feb 19, 2026, 4:00 PM EST - 6 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell


AIM ImmunoTech Transcript: Corporate Connect Webinar Series

Feb 11, 2026, 1:40 PM EST - 7 months ago

AIM ImmunoTech Transcript: Corporate Connect Webinar Series


AIM ImmunoTech Announces Commencement of Rights Offering

Feb 11, 2026, 8:30 AM EST - 7 months ago

AIM ImmunoTech Announces Commencement of Rights Offering


AIM ImmunoTech Registration statement: Registration Filing

Feb 10, 2026, 7:00 AM EST - 7 months ago

AIM ImmunoTech Registration statement: Registration Filing


AIM ImmunoTech Slides: Corporate presentation

Feb 4, 2026, 7:00 AM EST - 7 months ago

AIM ImmunoTech Slides: Corporate presentation


AIM ImmunoTech Registration statement: Registration Filing

Jan 29, 2026, 7:00 AM EST - 7 months ago

AIM ImmunoTech Registration statement: Registration Filing


AIM ImmunoTech Registration statement: Registration filing

Jan 23, 2026, 7:00 AM EST - 7 months ago

AIM ImmunoTech Registration statement: Registration filing


AIM ImmunoTech Transcript: AGM 2025

Dec 16, 2025, 11:00 AM EST - 9 months ago

AIM ImmunoTech Transcript: AGM 2025


AIM ImmunoTech Transcript: Virtual Investor Closing Bell Series

Dec 4, 2025, 4:00 PM EST - 9 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell Series


AIM ImmunoTech Quarterly report: Q3 2025

Nov 17, 2025, 4:00 PM EST - 10 months ago

AIM ImmunoTech Quarterly report: Q3 2025


AIM ImmunoTech Proxy statement: Proxy Filing

Oct 29, 2025, 8:30 AM EDT - 10 months ago

AIM ImmunoTech Proxy statement: Proxy Filing


AIM ImmunoTech to Attend the 2025 Maxim Growth Summit

Oct 20, 2025, 9:15 AM EDT - 10 months ago

AIM ImmunoTech to Attend the 2025 Maxim Growth Summit


AIM ImmunoTech Quarterly report: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 1 year ago

AIM ImmunoTech Quarterly report: Q2 2025


AIM ImmunoTech Earnings release: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 1 year ago

AIM ImmunoTech Earnings release: Q2 2025


IamJdubs
IamJdubs Sep. 11 at 1:01 PM
$AIM looking bleak here
0 · Reply
Mewz444
Mewz444 Sep. 11 at 1:00 PM
$AIM with the ebola outbreak seems to be 0 shares availability for shorting ~ 🍋💦 squeeze time ⏲️
0 · Reply
Chessdoc
Chessdoc Sep. 11 at 11:20 AM
$AIM https://abcnews.com/Health/wireStory/africas-top-health-body-warns-congos-ebola-outbreak-136345198
2 · Reply
Mewz444
Mewz444 Sep. 11 at 10:36 AM
$AIM 💲💲💲
0 · Reply
dmat12
dmat12 Sep. 10 at 8:20 PM
$AIM How can a stock have such high volume as AIM has had for the past few weeks and trade in such a narrow range? Pre market trading and after hours trading volume is high. And the stock price doesn't move more than a cent. Is it shorts covering their naked positions? Is our market maker involved? Somebody please explain.
2 · Reply
Packmentality
Packmentality Sep. 10 at 5:44 PM
$AIM Has to be one of the most mysterious shares ever. $2.5 million changed hands today for a share no one is interested in?….there has to be something to it’s never say die existence….
0 · Reply
Agp1
Agp1 Sep. 10 at 1:11 PM
$AIM why does Equels insist on representing the science himself. He has no more credibility in my book. I want to hear from the doctors and scientists. Not a lawyer that should have retired years ago. The pattern.. he speaks, stock tanks.
1 · Reply
Mewz444
Mewz444 Sep. 10 at 11:40 AM
$AIM wow
0 · Reply
setforyou
setforyou Sep. 10 at 10:18 AM
$AIM I asked Grok the hot penny stocks to buy and swing! $ELBM $WKSP $WKSP $DARE $LUCY
0 · Reply
runner01
runner01 Sep. 9 at 5:26 PM
$AIM The scam that keeps on scamming. What a fkn joke management should be on trial. Save yourselves.
1 · Reply
focafoca99
focafoca99 Sep. 9 at 3:14 PM
$AIM released a CEO Corner video outlining its Ampligen pancreatic cancer strategy and Phase 2 DURIPANC progress. https://www.rapidticker.com/news/aim-aim-immunotech-highlights-scientific-rationale-b90738
0 · Reply
AIM_ImmunoTech
AIM_ImmunoTech Sep. 9 at 1:20 PM
$AIM - In our latest CEO Corner, Tom Equels discusses the significant challenges associated with pancreatic cancer, including its highly immunosuppressive – or “cold” – tumor microenvironment, which can prevent the immune system from mounting an effective response and has historically limited the effectiveness of many immunotherapy approaches. https://vimeo.com/1225219727/91a420c432?share=copy&fl=sv&fe=ci
1 · Reply
AIM_ImmunoTech
AIM_ImmunoTech Sep. 9 at 1:18 PM
$AIM Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video https://aimimmuno.com/aim-immunotech-highlights-scientific-rationale-supportive-data-and-continued-advancement-of-ampligen-in-pancreatic-cancer-in-new-ceo-corner-video/
1 · Reply
50shadesoftrades
50shadesoftrades Sep. 9 at 1:03 PM
$AIM $AIM AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video https://www.stocktitan.net/news/AIM/aim-immuno-tech-highlights-scientific-rationale-supportive-data-and-xpg4omslpqav.html
0 · Reply
MAJTom
MAJTom Sep. 8 at 4:20 PM
$AIM ‘ing for the moon 🌕?
0 · Reply
IamJdubs
IamJdubs Sep. 8 at 3:04 PM
DFNS alert- $AIM parabolic mode don’t miss the boat
0 · Reply
jonjonson1234
jonjonson1234 Sep. 8 at 2:02 PM
$AIM "A Special Meeting of Stockholders (the “Special Meeting”) of AIM ImmunoTech Inc. (the “Company”) was held on July 15, 2026. ...Proposal 6: To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio in the range of up to 1-for-25, with such ratio to be determined by our Board of Directors in its sole discretion: For: 7,344,727 Against: 3,315,347 Abstain: 11,616 Based on the final voting results reported by the Inspector of Election, Proposal 6 was approved." This latest reverse split approval is still hanging over this stock like a Sword of Damocles
2 · Reply
TheLionofwallstreet
TheLionofwallstreet Sep. 8 at 9:37 AM
$AIM $BNC $GPRO top 10 premarket volume? Thats odd.
1 · Reply
alamoflags
alamoflags Sep. 8 at 2:01 AM
0 · Reply
IamJdubs
IamJdubs Sep. 8 at 1:20 AM
$AIM parabolic mode soon don’t miss the boat
0 · Reply
Stock_Catcher
Stock_Catcher Sep. 8 at 1:14 AM
Treasure Tuesday Watchlist Former Runners $WETO $AKAN $ORBS $GPUS $AIM
1 · Reply
Chessdoc
Chessdoc Sep. 8 at 1:13 AM
$AIM https://www.infectioncontroltoday.com/view/what-outbreak-metrics-can-cannot-tell-us-ebola-drc-response
0 · Reply